Financials Cerus Corporation

Equities

CERS

US1570851014

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.71 USD +0.59% Intraday chart for Cerus Corporation +1.79% -20.83%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 599.6 1,157 1,173 647.6 391.4 316.2 - -
Enterprise Value (EV) 1 599.6 1,157 1,173 647.6 391.4 316.2 316.2 316.2
P/E ratio -8.27 x -18.7 x -21.3 x -15.2 x -10.3 x -15.5 x -34.2 x -34.2 x
Yield - - - - - - - -
Capitalization / Revenue 8.03 x 12.6 x 8.96 x 4 x 2.5 x 1.77 x 1.56 x 1.46 x
EV / Revenue 8.03 x 12.6 x 8.96 x 4 x 2.5 x 1.77 x 1.56 x 1.46 x
EV / EBITDA -9.39 x -20.9 x -25.6 x -52 x -36.5 x 48.7 x 21.4 x 12.5 x
EV / FCF - - - - -11.3 x -13.2 x 31.6 x 16.9 x
FCF Yield - - - - -8.83% -7.56% 3.16% 5.91%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 142,089 167,142 172,266 177,421 181,197 184,890 - -
Reference price 2 4.220 6.920 6.810 3.650 2.160 1.710 1.710 1.710
Announcement Date 2/20/20 2/25/21 2/22/22 2/28/23 3/5/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 74.65 91.92 130.9 162 156.4 178.7 202.8 216.8
EBITDA 1 -63.82 -55.22 -45.79 -12.45 -10.72 6.494 14.8 25.3
EBIT 1 -66.23 -58.33 -48.94 -34.08 -30.05 -13.45 -3.008 -
Operating Margin -88.72% -63.46% -37.4% -21.03% -19.22% -7.53% -1.48% -
Earnings before Tax (EBT) 1 -70.98 -59.57 -54.06 -42.34 -37.32 -19.89 -9.442 -
Net income 1 -71.24 -59.86 -54.37 -42.78 -37.49 -20.05 -9.844 -
Net margin -95.44% -65.12% -41.55% -26.4% -23.98% -11.22% -4.85% -
EPS 2 -0.5100 -0.3700 -0.3200 -0.2400 -0.2100 -0.1100 -0.0500 -0.0500
Free Cash Flow 1 - - - - -34.54 -23.9 10 18.7
FCF margin - - - - -22.09% -13.37% 4.93% 8.63%
FCF Conversion (EBITDA) - - - - - - 67.54% 73.91%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/20/20 2/25/21 2/22/22 2/28/23 3/5/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 36.13 39.86 37.44 41 39.57 44.03 30.97 38.85 39.77 46.77 38.35 44.33 45.65 50.39 40.9
EBITDA 1 - -6.15 -3.661 -2.414 -2.676 -3.699 -9.754 -4.74 -0.972 4.743 -1.917 1.199 1.773 5.439 -1.792
EBIT 1 -11.13 -6.962 -9.848 -6.835 -7.447 -9.951 -14.15 -9.512 -5.243 0.976 -7.258 -4.15 -2.933 0.9264 -7.722
Operating Margin -30.79% -17.46% -26.3% -16.67% -18.82% -22.6% -45.67% -24.48% -13.18% 2.09% -18.93% -9.36% -6.43% 1.84% -18.88%
Earnings before Tax (EBT) 1 -12.36 -9.05 -12.21 -8.317 -8.454 -13.36 -15.56 -13.23 -7.208 -1.317 -8.882 -5.753 -4.537 -0.6772 -9.095
Net income 1 -12.44 -9.119 -12.28 -8.389 -8.482 -13.62 -15.62 -13.28 -7.267 -1.328 -8.917 -5.809 -4.592 -0.7126 -9.12
Net margin -34.42% -22.87% -32.81% -20.46% -21.43% -30.94% -50.43% -34.17% -18.27% -2.84% -23.25% -13.1% -10.06% -1.41% -22.3%
EPS 2 -0.0700 -0.0500 -0.0700 -0.0600 -0.0500 -0.0800 -0.0900 -0.0700 -0.0400 -0.0100 -0.0480 -0.0300 -0.0240 -0.004000 -0.0500
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/2/21 2/22/22 5/5/22 8/4/22 11/3/22 2/28/23 5/4/23 8/2/23 11/2/23 3/5/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - - -34.5 -23.9 10 18.7
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 8.94 1.62 0.91 2 4.6 8.5 9.6 9.6
Capex / Sales 11.97% 1.76% 0.7% 1.23% 2.94% 4.76% 4.73% 4.43%
Announcement Date 2/20/20 2/25/21 2/22/22 2/28/23 3/5/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.71 USD
Average target price
4.2 USD
Spread / Average Target
+145.61%
Consensus
  1. Stock Market
  2. Equities
  3. CERS Stock
  4. Financials Cerus Corporation